Delaware Supreme Court upholds Fresenius/Akorn decision
Delaware’s highest state court has confirmed that healthcare company Fresenius was entitled to pull out of its multibillion-dollar acquisition of Akorn after finding that the generic drugmaker had misrepresented the state of its data.
To read more
Subscribe to Global Data Review
Subscribe & start reading now!
The one-stop information source and community touchpoint, with coverage from across the areas of
- Data protection
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10